List of Studies ( Metabolite:CE 28:5)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004095 | AN006788 | Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics | Cultured cells | Human | Cancer | Amgen | LC-MS |
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003760 | AN006174 | Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003758 | AN006170 | Untargeted lipidomics of gemcitabine-resistant cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003328 | AN005453 | Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics | Stem cells | Human | Multiple sclerosis | University of Colorado Denver | LC-MS |
